Kwality Pharmaceuticals enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY24Mar 2024FY23Mar 2023FY22Mar 2022
———10.9
98.198.1——
324324——
30.3%30.3%——
Reference items — trailing FY values
307307251456
66.666.660.3172
47.147.145.4161
——42.263.1
——−5.57.9
——−7.07.2
29.829.847.755.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KPL₹3,696.70

Kwality Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARSUNLOC
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Current
last close
- Cash, Equiv & ST Investments10.9———
+ Total Debt——98.198.1
Total Capital——324.1324.1
Total Debt/Total Capital——30.2830.28
Reference Items — Trailing FY Values
Sales456.1251.0307.2307.2
EBITDA171.760.366.666.6
EBIT161.145.447.147.1
Operating Cash Flow63.142.2——
Free Cash Flow7.9-5.5——
FCFF (free cash flow to the firm)7.2-7.0——
Capital Expenditure55.247.729.829.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.